Percutaneous Tibial Nerve Stimulation for Overactive Bladder Receives Affirmation of Efficacy and Safety in Agency for Healthcare Research and Quality Report

Uroplasty, Inc.

announced today that the United States Agency for Healthcare Research and Quality in a recently issued document titled "Nonsurgical Treatments for Urinary Incontinence in Adult Women: Diagnosis and Comparative Effectiveness" included favorable statements on the safety and effectiveness of percutaneous tibial nerve stimulation for overactive bladder. Uroplasty's Urgent® PC Neuromodulation System is currently the only FDA-cleared product in the U.S. that delivers PTNS.